Evidence map›Paper›PMID 28619116›Full record

Trial reportBMC research notes2017

Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer.

Lene Thorsen, Camilla Kirkegaard, Jon Håvard Loge, Cecilie E Kiserud, Merethe Lia Johansen, Gunhild M Gjerset, Elisabeth Edvardsen, Hanne Hamre, Tone Ikdahl, Sophie D Fosså

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in BMC research notes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01749774 (Physical Activity and Testicular Cancer - a Pilot Study), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01749774 nacompletednot on this map

Physical Activity and Testicular Cancer - a Pilot Study: Feasibility and Effects of a Program Including Information, Counseling and a Physical Activity Program for Patients With Testicular Cancer During and After Chemotherapy

TypeinterventionalSponsorOslo University HospitalRan2012 to 2013Enrolled13ConditionsTesticular CancerArmsPhysical activity counseling
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lene ThorsenNational Advisory Unit on Late Effects After Cancer Treatment, Oslo University Hospital, Box 4950, Nydalen, 0424 OSLO, Oslo, Norway. LKA@ous-hf.no.
Camilla KirkegaardClinical Manager, Medical Affairs, Coloplast A/S, Humlebæk, Denmark.
Jon Håvard LogeDepartment of Behavioral Sciences in Medicine, University of Oslo/Regional Advisory Unit in Palliative Care, Oslo University Hospital, Oslo, Norway.
Cecilie E KiserudNational Advisory Unit on Late Effects After Cancer Treatment, Oslo University Hospital, Box 4950, Nydalen, 0424 OSLO, Oslo, Norway.
Merethe Lia JohansenDepartment of Cancer Rehabilitation, Oslo University Hospital, Oslo, Norway.
Gunhild M GjersetNational Advisory Unit on Late Effects After Cancer Treatment, Oslo University Hospital, Box 4950, Nydalen, 0424 OSLO, Oslo, Norway.
Elisabeth EdvardsenDepartment of Pulmonary Medicine, Oslo University Hospital, Oslo, Norway.
Hanne HamreDepartment of Oncology, Akershus University Hospital, Lorenskog, Norway.
Tone IkdahlAkershus University Hospital, Lorenskog, Norway.
Sophie D FossåNational Advisory Unit on Late Effects After Cancer Treatment, Oslo University Hospital, Box 4950, Nydalen, 0424 OSLO, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGiven the risk of developing acute and long-term adverse effects in patients receiving cisplatin-based chemotherapy for testicular cancer (TC), risk-reducing interventions, such as physical activity (PA), may be relevant. Limited knowledge is available on the challenges met when conducting PA intervention trials in patients with TC during and shortly after chemotherapy. The aims of the present feasibility study are therefore to determine patient recruitment, compliance and adherence to a PA intervention.

resultsPatients with metastatic TC referred to cisplatin-based chemotherapy were eligible. They followed an individual low-threshold PA intervention, including counseling from a personal coach during and 3 months after chemotherapy. Outcomes were recruitment rate, compliance rate and adherence to the intervention including preferences for type of PA and barriers for PA. During 8 months 12 of 18 eligible patients were invited, all consented, but three dropped out. Walking and low intensity activities were preferred and nausea and feeling unwell were the most often reported barriers towards PA. DISCUSSION: In order to achieve adequate recruitment, compliance and complete data in future PA intervention trials, close cooperation with treating physicians, individual PA plans and availability of personalized coaching are required. Trial registration NCT01749774, November 2012, ClinicalTrials.gov.

Indexed as

CounselingAdultAntineoplastic Combined Chemotherapy ProtocolsCisplatinExerciseHumansLymphatic MetastasisMaleMiddle AgedNauseaPatient CompliancePatient SelectionPrecision MedicineProspective StudiesSeminomaTesticular NeoplasmsCisplatinChemotherapyFeasibilityPhysical activityTesticular cancer

Identifiers

PMID28619116
PMCPMC5472911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.